©The Author(s) 2017.
World J Gastroenterol. Sep 28, 2017; 23(36): 6685-6693
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6685
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6685
Table 1 Demographics and operative outcomes
| Characteristic | n (%) |
| Age (yr)1 | 59 (23-78) |
| Gender | |
| Male | 75 (52.8) |
| Female | 67 (47.2) |
| Albumin level (g/L)2 | 36.74 ± 4.93 |
| CA19-9 | |
| > 200 | 82 (57.7) |
| < 200 | 60 (42.3) |
| Radiological examination | |
| Contrast-enhanced US | 8 (5.6) |
| Contrast-enhanced CT | 43 (30.3) |
| MRI + MRCP | 91 (64.1) |
| Operative time (min)2 | 429.47 ± 134.19 |
| Blood loss (ml)1 | 600 (180-4000) |
| Transfusion | 76 (53.5) |
| R0 resection | 107 (75.4) |
| Differentiation degree | |
| Well differentiated | 14 (9.9) |
| Moderately differentiated | 90 (63.4) |
| Poorly differentiated | 38 (26.8) |
| Perineutral invasion positive | 69 (48.6) |
| N stage | |
| N0 | 89 (62.7) |
| N1 | 53 (37.3) |
| Tumor diameter (mm)1 | 30 (12-55 |
| Hospital stay1 | 19 (5-115) |
- Citation: Li B, Xiong XZ, Zhou Y, Wu SJ, You Z, Lu J, Cheng NS. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma. World J Gastroenterol 2017; 23(36): 6685-6693
- URL: https://www.wjgnet.com/1007-9327/full/v23/i36/6685.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i36.6685